Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of anakinra (IL-1 ra) and pegsunercept
(PEG sTNF-RI) when they are used together in improving the signs and symptoms of rheumatoid
arthritis. The study will also evaluate the safety of the combination treatment and its
effect on slowing down bone and joint destruction due to rheumatoid arthritis. The results
will be compared to the effect when only 1 single medication (anakinra or pegsunercept) is
used.